|
C9ORF72 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.245900E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.420440E-02 |
| Normal-vs-Stage2 |
5.424300E-02 |
| Normal-vs-Stage3 |
5.262400E-01 |
| Normal-vs-Stage4 |
5.140400E-01 |
| Stage1-vs-Stage2 |
5.917000E-01 |
| Stage1-vs-Stage3 |
2.979500E-02 |
| Stage1-vs-Stage4 |
1.190360E-01 |
| Stage2-vs-Stage3 |
1.029760E-01 |
| Stage2-vs-Stage4 |
1.428400E-01 |
| Stage3-vs-Stage4 |
9.022600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.532500E-02 |
| Normal-vs-AfricanAmerican |
8.303600E-03 |
| Normal-vs-Asian |
5.569600E-01 |
| Caucasian-vs-AfricanAmerican |
1.050800E-01 |
| Caucasian-vs-Asian |
9.645200E-01 |
| AfricanAmerican-vs-Asian |
4.893200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.751970E-01 |
| Normal-vs-Female |
1.224310E-02 |
| Male-vs-Female |
1.018000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.995600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.620110E-02 |
| Normal-vs-Age(61-80Yrs) |
2.139200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.795800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.407000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.142400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.605400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.954100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.290600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.648800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.817900E-04 |
| Normal-vs-Grade 2 |
2.263800E-03 |
| Normal-vs-Grade 3 |
3.441000E-01 |
| Normal-vs-Grade 4 |
4.893000E-01 |
| Grade 1-vs-Grade 2 |
1.465010E-01 |
| Grade 1-vs-Grade 3 |
1.595410E-03 |
| Grade 1-vs-Grade 4 |
2.762800E-04 |
| Grade 2-vs-Grade 3 |
3.815400E-03 |
| Grade 2-vs-Grade 4 |
1.223310E-04 |
| Grade 3-vs-Grade 4 |
6.909900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.555800E-04 |
| Normal-vs-ccB subtype |
7.676000E-01 |
| ccA subtype-vs-ccB subtype |
8.3743000000025E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.640100E-02 |
| Normal-vs-N1 |
6.370200E-01 |
| N0-vs-N1 |
1.535640E-01 |
|
|
